Murat Kalayoglu, president and CEO of Cartesian Therapeutics, discusses the company’s RNA-engineered cell therapies, how they work, and how the company is pushing the use of cell therapies beyond cancer.

Overcoming the Limitations of Conventional Cell Engineering

<p>RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy. </p>

Business

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Share Overcoming the Limitations of Conventional Cell Engineering

Sign up to save your podcasts

Overcoming the Limitations of Conventional Cell Engineering

Overcoming the Limitations of Conventional Cell Engineering